According to the WHO more than 300 million people worldwide suffer from depression, and over 50% of them are never diagnosed. Moodpath is an app developed in cooperation with psychotherapists, doctors and patients to identify first symptoms early in order to detect depression before a visit to the doctor.
Rather than replacing psychotherapy, the app accompanies and supports it, making it a complement to the existing range of treatments offered by Schoen Clinic, which will acquire Berlin-based Aurora Health, the creator of Moodpath, on October 1, 2019.
Schoen Clinic has been involved in the treatment of mental and psychosomatic illnesses for more than 30 years. The clinic group has also been offering MindDoc for several years, a successful online therapy program for patients with mental illnesses such as depression, eating disorders, anxiety and obsessive-compulsive disorders.
“With MindDoc we currently offer online therapy with video conferencing and chat,” said Nicolas Stoetter, Head of the Schoen Clinic Digital Lab. “The Moodpath app will enable us to expand our services with a scientifically developed screening for the detection and documentation of depression, as well as unaccompanied self-help. Thus, in the future we offer a portfolio that is unique on the market.“
“Our range of online services is a response to the mobile and digital lifestyle,” said COO Christopher Schön. “It supports our core business outpatient and inpatient care and at the same time offers completely new entrepreneurial opportunities. With the combination of MindDoc and Moodpath, we cover nearly every aspect currently possible in e-mental health. In the long term, we want to offer a technology platform that covers all disorders and that is available to our patients on various devices.”